BPC
CLDX icon

Bryce Point Capital’s Celldex Therapeutics CLDX Stock Holding History

Bryce Point Capital’s Portfolio CLDX Stock Details CLDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-16,265
Closed -$351K – 195
2025
Q1 		$351K Sell
16,265
-7,525
-32% -$162K 0.26% 157
2024
Q4 		$601K Buy
+23,790
New +$601K 0.17% 162